Chanice Henry | 08/02/2015
The CRISPR tool has attracted worldwide attention from the R&D industry in regards to its capabilities for gene editing.CRISPR alongside the use of the Cas9 protein enables the ability to target a specific section of a gene sequence and edit it – by deleting and sometimes replacing the function with a new element. Until CRISPR’s discovery by Jennifer Doudna and her lab in 2013, options were relatively limited in regards to precise gene editing. This new technique acts as a tool to...
To continue reading this story Click Here
RECOMMENDED
Upcoming Events
DigIT Pharma AI Commercial Excellence & Health 2025
September 01 - 03, 2025
Palace Hotel Berlin, Germany
Register Now |
View Agenda |
Learn More
AI for Pharma & Healthcare
23 - 25 September, 2025
Amsterdam
Register Now |
View Agenda |
Learn More